ストックスクリーナーアプリを入手
1.51
1.95%
-0.03
プレマーケット:
1.51
前日終値:
$1.54
開ける：
$1.54
24時間の取引高:
568.41K
Relative Volume:
0.42
時価総額：
$104.45M
収益：
-
当期純損益:
$-89.66M
株価収益率:
-0.6238
EPS:
-2.4205
ネットキャッシュフロー:
$-81.90M
1週間 パフォーマンス:
-2.58%
1か月 パフォーマンス:
-9.04%
6か月 パフォーマンス:
-72.84%
1年 パフォーマンス:
+2.72%
1日の値動き範囲:
$1.495
$1.595
1週間の範囲:
$1.37
$1.595
52週間の値動き範囲:
$1.01
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Compare PEPG vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.51 | 106.52M | 0 | -89.66M | -81.90M | -2.4205 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-09 | 開始されました | Guggenheim | Buy |
| 2024-12-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-07-31 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-21 | 開始されました | H.C. Wainwright | Buy |
Pepgen Inc (PEPG) 最新ニュース
[EFFECT] PepGen Inc. SEC Filing - Stock Titan
PEPG Stock Price, Quote & Chart | PEPGEN INC (NASDAQ:PEPG) - ChartMill
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program - BioSpace
PepGen’s PGN-EDODM1 Shows Promising Safety and Efficacy in Myotonic Dystrophy Type 1 Clinical Trials – FREEDOM2 Study Update - Minichart
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting - PharmiWeb.com
PepGen unveils new PGN-EDODM1 clinical data at IDMC-15 - Traders Union
PepGen Highlights DM1 Program Progress in Updated Presentation - TipRanks
H.C. Wainwright reiterates PepGen stock rating on data outlook - Investing.com
PepGen updates corporate presentation, highlights FREEDOM2 milestones and PGN-EDODM1 data - TradingView
PepGen (NASDAQ: PEPG) details DM1 trial data and cash runway outlook - Stock Titan
H.C. Wainwright reiterates PepGen stock rating on data outlook By Investing.com - Investing.com Canada
PepGen (PEPG) loses 14.3% in 4 weeks, here's why a trend reversal may be around the corner - MSN
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance Singapore
PepGen files to offer up to $400 mln in securities from time to time - marketscreener.com
PepGen Files To Offer Up To $400 Mln In Securities From Time To Time - TradingView
According to documents submitted to the SEC, biotechnology company PepGen Inc. has signed a new sales agreement, which will completely replace the company's previous sales arrangement. - Bitget
PepGen (NASDAQ: PEPG) ups capital flexibility with $400M shelf and $100M ATM - Stock Titan
Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now? - Insider Monkey
Why is PepGen stock sinking Tuesday? - MSN
PepGen (PEPG) upgraded to buy: Here's what you should know - MSN
Viking Global reports 3.48M shares in PepGen (NASDAQ: PEPG) - Stock Titan
[SCHEDULE 13G/A] PepGen Inc. Amended Passive Investment Disclosure - Stock Titan
TradingKey - TradingKey
Wedbush Maintains PepGen(PEPG.US) With Buy Rating, Cuts Target Price to $4 - Moomoo
PepGen Inc. Stock 12‑Month Price Target Cut to $10, Implies 495% Upside - TradingView
PepGen (PEPG) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Wedbush Trims Price Target on PepGen to $4 From $5, Maintains Outperform Rating - marketscreener.com
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - BioSpace
PepGen: $132.3M of Cash as of March 31 Sufficient to Fund Ops Through FREEDOM2 12.5 Mg/kg MAD Readout and Into 2H 2027 >PEPG - Moomoo
First quarter 2026 financial results released as PepGen announces new corporate developments - Traders Union
PepGen Q1 loss narrows as operating expenses fall - TradingView
PepGen (PEPG) posts Q1 2026 loss, updates FREEDOM2-DM1 trial and FDA hold - Stock Titan
PepGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
PepGen (NASDAQ: PEPG) cuts Q1 2026 loss as cash reaches $132.3M - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - ACCESS Newswire
MSN Money - MSN
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PepGen Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Pictet Asset Management Holding SA Purchases 871,059 Shares of PepGen, Inc. $PEPG - MarketBeat
PepGen falls 20% despite earnings beat on FDA hold concerns By Investing.com - Investing.com Nigeria
PepGen crashes after mid-stage trial data for muscle disorder therapy - MSN
Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - FinancialContent
[ARS] PepGen Inc. SEC Filing - Stock Titan
PepGen (NASDAQ: PEPG) details 2026 virtual meeting and auditor vote - Stock Titan
PepGen advances momentum with Palo Alto meeting on DM1 community engagement - Traders Union
PepGen shares slide 20% as FDA clinical hold overshadows earnings beat - MSN
Wedbush Maintains PepGen (PEPG) Outperform Recommendation - MSN
Pepgen Inc (PEPG) 財務データ
収益
当期純利益
現金流量
EPS
2.98%
1.33%
大文字化:
|
ボリューム (24 時間):